- Home
- UHAL vs BSX Comparison
UHAL vs BSX Comparison
Compare UHAL & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHAL
- BSX
- Stock Information
- Founded
- UHAL 1945
- BSX 1979
- Country
- UHAL United States
- BSX United States
- Employees
- UHAL N/A
- BSX N/A
- Industry
- UHAL Rental/Leasing Companies
- BSX Medical/Dental Instruments
- Sector
- UHAL Consumer Discretionary
- BSX Health Care
- Exchange
- UHAL Nasdaq
- BSX Nasdaq
- Market Cap
- UHAL 11.9B
- BSX 138.4B
- IPO Year
- UHAL N/A
- BSX 1992
- Fundamental
- Price
- UHAL $60.14
- BSX $107.04
- Analyst Decision
- UHAL
- BSX Strong Buy
- Analyst Count
- UHAL 0
- BSX 22
- Target Price
- UHAL N/A
- BSX $112.86
- AVG Volume (30 Days)
- UHAL 135.4K
- BSX 7.9M
- Earning Date
- UHAL 08-06-2025
- BSX 07-23-2025
- Dividend Yield
- UHAL N/A
- BSX N/A
- EPS Growth
- UHAL N/A
- BSX 15.23
- EPS
- UHAL 1.87
- BSX 1.37
- Revenue
- UHAL $5,828,665,000.00
- BSX $17,554,000,000.00
- Revenue This Year
- UHAL $5.55
- BSX $17.50
- Revenue Next Year
- UHAL $4.94
- BSX $10.75
- P/E Ratio
- UHAL $32.41
- BSX $78.36
- Revenue Growth
- UHAL 3.61
- BSX 19.36
- 52 Week Low
- UHAL $56.28
- BSX $71.88
- 52 Week High
- UHAL $79.04
- BSX $107.48
- Technical
- Relative Strength Index (RSI)
- UHAL 37.23
- BSX 67.74
- Support Level
- UHAL $60.34
- BSX $100.90
- Resistance Level
- UHAL $61.88
- BSX $107.05
- Average True Range (ATR)
- UHAL 1.20
- BSX 1.56
- MACD
- UHAL -0.23
- BSX 0.64
- Stochastic Oscillator
- UHAL 0.00
- BSX 98.45
About UHAL U-Haul Holding Company
U-Haul Holding Co is an American moving truck, trailer, and self-storage rental company. The company also provides moving boxes, packing supplies, LPG (propane) refills, trailer hitch and wiring installation, storage container rentals, and other services. It has three reportable segments Moving and Storage, Property and Casualty Insurance, and Life Insurance. The majority of its revenue comes from the Moving and Storage segment.
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.